Thermo Fisher Scientific Expands To Bioproduction Products

Thermo Fisher Scientific Expands To Bioproduction Products

Author: ChemistryViews

Thermo Fisher Scientific Inc. announced that it has signed an agreement to acquire certain assets of the polystyrene roller bottle product line from BD, a global technology company that develops, manufactures and sells medical devices, instruments and reagents. Roller bottles are one of several production cell culture platforms which are used for the production of vaccines, monoclonal antibodies, recombinant proteins and cell-based therapeutics.

The transaction is expected to close in the second quarter of 2011, subject to satisfaction of certain closing conditions. Manufacturing of the newly acquired line of polystyrene roller bottles will be relocated to Thermo Fisher’s Fairport, N.Y. facility.


Leave a Reply

Your email address will not be published.